Delivery Order SPE2DB24D2011-SPE2DB25FBQGY
- Not listed
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, with a total ceiling value of $1,753.30. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance running through February 2025. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,051.98 and covers the supply of Repatha 140 mg/ml SureClick medication. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,768.80 and a completion date of May 10, 2023. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency for this award. The contract is not designated as a set-aside. AmerisourceBergen also holds a...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,454.48 firm-fixed-price delivery order has a completion date of January 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $6,422.85 firm fixed-price delivery order has a completion date of May 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of the pharmaceutical product Repatha 140 mg/mL SureClick to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,620.11 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 26, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,224.04, is a delivery order for the medication Repatha 140 mg/ml SureClick. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication, with a ceiling value of $2,028.77 and a performance period extending to April 11, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,720.24 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBQGYDelivery Order
This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $18,929.40. It has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is likely a delivery order under this larger IDC contract. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 3/21/25 |